Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

372

HTML

2737

Figures (1-4)

123

Tables (1-3)

132

Sum=3364

Jul 15, 2003 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jul 15, 2003; 9(7): 1415-1420
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1415

Full Size Figure Download Figure

Figure 1 FasL was strongly expressed in moderately differentiated adenocarcinoma of stomach (+++). S-P × 400.

Citation: Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y. Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 2003; 9(7): 1415-1420
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1415.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1415